Home

Welcome to MyIDSA

Welcome to MyIDSA, IDSA’s Member-Only Community! Connect with Colleagues, Share Resources, Start or Join a Lively Discussion. Join us…It’s Infectious!

JOIN THE DISCUSSION

Recent Discussions

  • Profile Picture

    IVDU and OPAT

    Posted in: IDea Exchange

    We had a discussion here last year about the use of a "contractual model" for discharge of PWID with IV access to facilitate OPAT. There were various opinions, and I'm sure we have all held most of them at one time or another. Rebecca Shadowen had at ...

  • Profile Picture

    Ebola PHEIC

    Posted in: IDea Exchange

    [I'm sharing a thread started on LinkedIn, which is in response to changes in the Ebola crisis.] We now have declaration of a PHEIC by the World Health Organization . While many have felt this should have been done months ago, there has been precious ...

  • Posted in: HIV Community

    In reply to Dr. Smith's comments on PrEP and TAF Truvada is the only medication currently approved for PrEP and therefore I think it is the only responsible choice at this time. Your comment about increased STI rates is commonly heard but the majority ...

New Guidelines Update

2019 IDSA Clinical Practice Guideline for Asymptomatic Bacteriuria Released

research

Doctors should think carefully before testing patients for a urinary tract infection (UTI) to avoid over-diagnosis and unnecessary antibiotic treatment, according to updated asymptomatic bacteriuria (ASB) guidelines released by the Infectious Diseases Society of America (IDSA) and published in Clinical Infectious Diseases.

 

Read More

Member Spotlight

Karen Carroll, MD, FIDSA

IDSA member Karen Carroll, MD, FIDSA has been appointed to the Centers for Medicare and Medicaid Services Advisory Panel on Clinical Diagnostic Laboratory Tests following a nomination from IDSA. The Panel advises the CMS Administrator and the Secretary of the Department of Health and Human Services on issues related to clinical diagnostic laboratory tests, including the establishment of payment rates and the factors used in determining coverage and payment processes for new tests. 

Dr. Carroll is the director of the Division of Medical Microbiology and a professor of pathology at the Johns Hopkins University School of Medicine. Her research interests include diagnostic test evaluation and development for the detection of microbial pathogens in clinical specimens, and she has served as an inaugural member of the IDSA Diagnostics Committee.

News

  • Record Measles Numbers Underscore Urgency of Heightened Vaccine Outreach, Access

    The announcement by the Centers for Disease Control and Prevention Wednesday that measles cases in the United States have reached numbers unseen ...
  • House Spending Bill Recognizes Need to Strengthen Health Responses and Research

    Once again rejecting proposed cuts to vital domestic and global health programs and research, House appropriators Wednesday approved funding ...

Help attract the best and brightest to the field of infectious diseases.

IDSA Foundation

I always like mystery stories growing up and you have to be very astute...You have to look at the symptoms, the geography, the home and social situation to solve the mystery of their problem.
Susan Bleasdale, MD